Open an account

Trulieve Cannabis

TRLV · NYSE

$10.79+$0.51 (+4.96%)TodayMarket closed ·
Prev close $10.28

About TRLV

Trulieve Cannabis Corp. engages in the provision of medical cannabis products and services. The company is headquartered in Quincy, Florida and currently employs 5,000 full-time employees. The company went IPO on 2018-09-25. The firm has established cannabis operations in three hubs: Southeast, Northeast, and Southwest. Each of its three regional hubs is anchored by market positions in the cornerstone states of Florida, Pennsylvania, and Arizona. The firm operates in regulated markets that require expertise in cultivation, manufacturing, and retail. The firm utilizes various extraction techniques, including supercritical ethanol extraction, carbon dioxide extraction, hydrocarbon extraction, and mechanical separation. In addition, it utilizes distillation, purification, and manufacturing technologies to further refine extracts and transform them into a wide variety of finished products. Its brands include premium-tier brands Avenue, Cultivar Collection, and Muse; mid-tier brands Modern Flower, Alchemy, Momenta, and Sweet Talk, and value tier brands Co2lors, Loveli, Roll One, and Trekkers.

Employees
5,000
Headquarters
Quincy, Florida
Listed
Sep 25, 2018
Sector
Health Care
Industry
Pharmaceuticals
Website
trulieve.com

TRLV key statistics

Market cap
2.08B
Price-earnings ratio
0.00
Dividend yield
—
Average volume
2.00M
Volume
1.18M
Open price
$10.25
High today
$10.95
Low today
$10.13
52 Week high
$13.28
52 Week low
$4.62

Trulieve Cannabis (TRLV) at a glance

As of Oct 20, 2026, Trulieve Cannabis (TRLV) shares are priced at $10.79, giving the company a market cap of 2.08B and a price-to-earnings ratio of 0.00.

Today the stock has traded between $10.13 and $10.95. The current price is 6.6% above the day's low and 1.5% below its high.

Volume so far is 1.18M shares, below the average of 2.00M shares a day.

Over the past year Trulieve Cannabis has ranged from $4.62 to $13.28, and now sits 71% of the way up that range.

Trulieve Cannabis met or beat analyst EPS estimates in 1 of the last 8 quarters. In Q2 FY26 it reported -$2.10 per share against an estimate of $0.0639.

The average analyst price target is $17.92, 66.1% above the current price, from 1 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 1 analyst rating say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 9 analystsAvg $17.92
Low
$10.87
Now
$10.79
High
$22.05

TRLV earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 1 of the last 8 quarters, by 165.4% on average.

  1. Q3 FY24: reported -$0.33 per share against an estimate of -$0.1332
  2. Q4 FY24: reported -$0.27 per share against an estimate of -$0.2632
  3. Q1 FY25: reported -$0.17 per share against an estimate of -$0.0775
  4. Q2 FY25: reported -$0.07 per share against an estimate of -$0.0663
  5. Q3 FY25: reported -$0.14 per share against an estimate of -$0.0918
  6. Q4 FY25: reported -$0.23 per share against an estimate of -$0.0238
  7. Q1 FY26: reported $0.01 per share against an estimate of -$0.0153
  8. Q2 FY26: reported -$2.10 per share against an estimate of $0.0639

TRLV news

  • Full Transcript: Trulieve Cannabis Q2 2026 Earnings Call

  • Press releasePRNewswire

    Trulieve Repays $65 Million Mortgage Strengthening Balance Sheet

  • Press releasePRNewswire

    Trulieve Cannabis Corp. to Hold Third Quarter 2026 Results Conference Call on November 5, 2026

  • Avi Kapoor

    Crude Oil Rises Over 1%; Conagra Brands Earnings Top Views

  • Avi Kapoor

    Concentrix Posts Mixed Q3 Results, Joins Cal-Maine Foods And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

  • Press releasePRNewswire

    Trulieve Announces Exclusive Master Licensing Agreement with Connected for Florida and Texas

  • Press releasePRNewswire

    Trulieve Cannabis Corp. Added to S&P Total Market and S&P Completion Indices

  • Press releasePRNewswire

    Trulieve to Open Medical Cannabis Dispensary in Dunwoody, Georgia

Similar companies

Companies in the same industry as Trulieve Cannabis

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.